Market Overview

Morning Market Movers

Share:
Related RPRX
Repros Submits New Drug Application to FDA for Androxal
Morning Market Movers
Related KYTH
CORRECTION: Kythera Reports FDA Acceptance of ATX-101 NDA, PDUFA Date Set at May 13, 2015
Kythera Reports FDA Acceptance of ATX-101 NDA, PDUFA Date Set at May 13, 2015
Next Week In Biotech: Pacira PDUFA, Geron And Dendreon Report (Seeking Alpha)

Repros Therapeutics (NASDAQ: RPRX) moved up 26.15% to $26.82 after the company announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal®.

Kythera Biopharmaceuticals (NASDAQ: KYTH) jumped 24.43% to $41.72 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat.

Agenus (NASDAQ: AGEN) rose 22.99% to $3.37 after the company reported positive follow-on Phase 2 results for brain cancer vaccine.

Aeropostale (NYSE: ARO) shares jumped 18.23% to $10.18 after private equity firm Sycamore Partners bought a 7.96% stake in the company.

Posted-In: Morning Market MoversNews Intraday Update Markets Movers

 

Related Articles (AGEN + ARO)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→